Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2025-12-25 @ 2:31 AM
NCT ID:
NCT02288234
Eligibility Criteria:
Inclusion Criteria:
-received at least 1 dose of telavancin since January 1, 2015
Exclusion Criteria:
* Participation in an interventional research study or clinical trial involving telavancin after January 01, 2015
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02288234
Study Brief:
Protocol Section:
NCT02288234